Treatment News : Well-Controlled HIV and High CD4s Can Reduce Risk of Cervical HPV Infection

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » April 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


April 8, 2013

Well-Controlled HIV and High CD4s Can Reduce Risk of Cervical HPV Infection

A suppressed viral load and a high CD4 count are associated with a reduced risk of persistent cervical human papillomavirus (HPV) infection, lessening the risk of cervical cancer, aidsmap reports. Publishing their findings in the Journal of Infectious Diseases, Belgian investigators designed a prospective study of 652 HIV-positive women who received routine cervical smear tests between 2002 and 2011.

At the outset of the study, 43 percent of the women had a high-risk cervical HPV infection. After a median 103-month follow-up, about 54 additional women also became infected with a high-risk strain of the virus, resulting in a cumulative 51 percent prevalence among the cohort. Sixty-three women cleared the infection, while the virus persisted in 77 others. After conducting an analysis to rule out other factors, the researchers concluded that maintaining a suppressed viral load for more than 40 months and a CD4 count above 500 for more than 18 months was significantly associated with a lowered risk of persistent cervical HPV infection.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: persistent cervical human papillomavirus, HPV, cervical cancer, CD4 count, viral load, Journal of Infectious Diseases.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.